Save 29% on select Life Memberships using code LEAP!

Does Race Affect Treatment Initiation and Outcomes for Chronic Hepatitis B?

April 10, 2023

 • 

Read time:

5-15 mins
Liver Pills Medication Organ Medicine
Presented by Health Lab

Chronic hepatitis B, or CHB, is a liver condition that affects nearly 2.4 million Americans, more disproportionately, those of Asian or African descent. Anna Lok, M.D., assistant dean for clinical research and director of clinical hepatology at Michigan Medicine, conducted a study involving the treatment of CHB to focus on treatment differences to see if there was a racial bias in the process.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.